Associated Partner

University of Manchester

Manchester,

United Kingdom

The University of Manchester in the United Kingdom is a powerhouse of research and is ranked among the leading research universities globally. In this project, the University of Manchester will be involved in WP 1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Key People Involved:

Matthew Krebs

MD, PhD, Chief Investigator DETERMINE, University of Manchester

Kate Duffus

PhD, Research Project Manager in Experimental Cancer Medicine, University of Manchester

Louise Carter

MD, PhD, Co-Investigator DETERMINE, University of Manchester

Natalie Cook

MD, PhD, Co-Investigator DETERMINE, University of Manchester

partners

Beneficiaries & Associated Partners

Beneficiary

Helsinki University Hospital (HUS)

Work package leader dissemination (WP8). Will in addition contribute to WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Beneficiary

Oslo University Hospital (OUS)

Project coordinator (WP7), work package leader control cohorts (WP2) and expansion cohorts (WP3). Will in addition contribute to WP 1 (data aggregation), WP 5 (implementaion), WP6 (social innovation) and WP8 (dissemination)

Associated Partner

National Cancer Institute (NVI)

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).